BDMAI

Infinite Right-to-Left Scrolling Marquee
Latest Circulars

Sectoral Plan for Effective Logistics – Pharma Sector

BDMAI News Letter – Material contribution by Members

Interaction with USP, India team with our Member companies on 9.1.2025 at 2.00 p.m.

Pharma MSME Industry Meet – 24.1.2025

Delays in obtaining URN / Permission for Destruction of Controlled Substances from NCB

MOU Signing Ceremony between BDMAI and Telangana Council of Higher Education

Implementation of Schedule M – Online Demo by CDSCO for filling application on 14th February 2025

Allotment of land in Green Pharma City, Telangana

Launch of a Scheme for Promotion of Research & Innovation in Pharma MedTech (PRIP) Sector by Department of Pharmaceuticals, Govt. of India

New Guidelines for obtaining NoC for Export of Unapproved/Approved New Drugs

Free In-House Up-Skilling Programme by LSSSDC for Employees BDMAI Member companies

ICH Guidelines- Q7- Telugu Translated version

Special offer by Avila International – Travel Package – CPhI China

Online Application for implementation of Schedule M

Sectoral Plan for Effective Logistics – Pharma Sector

BDMAI News Letter – Material contribution by Members

Interaction with USP, India team with our Member companies on 9.1.2025 at 2.00 p.m.

Pharma MSME Industry Meet – 24.1.2025

Delays in obtaining URN / Permission for Destruction of Controlled Substances from NCB

MOU Signing Ceremony between BDMAI and Telangana Council of Higher Education

Implementation of Schedule M – Online Demo by CDSCO for filling application on 14th February 2025

Allotment of land in Green Pharma City, Telangana

Launch of a Scheme for Promotion of Research & Innovation in Pharma MedTech (PRIP) Sector by Department of Pharmaceuticals, Govt. of India

New Guidelines for obtaining NoC for Export of Unapproved/Approved New Drugs

Free In-House Up-Skilling Programme by LSSSDC for Employees BDMAI Member companies

ICH Guidelines- Q7- Telugu Translated version

Special offer by Avila International – Travel Package – CPhI China

Online Application for implementation of Schedule M

Objectives

“The Association works   for consolidation  of  the  gains of the industry and serves  as  a catalyst between Government and the  Industry  on the  various issues for the growth of the Industry”:

  • Strengthening India’s Pharmaceutical Industry

    • Build on India’s existing strength in manufacturing and distribution.
    • Significantly enhance R&D capabilities.
    • Become a leading player in the global pharmaceutical market.

 

  • Serving as a Common Forum

    • Promote discussions on key issues affecting the Bulk Drug Industry in India.
    • Provide a platform for members to formulate collective views on national, economic, financial, and commercial policies impacting industry growth.

 

  • Encouraging Collaboration Among Members

    • Foster mutual help and cooperation among members.

 

  • Advocacy & Representation

    • Represent members’ collective opinions on industry-related matters.
    • Engage with State and Central Government authorities to influence policy decisions affecting the bulk drug industry.

 

  • Information Sharing & Publications

    • Disseminate relevant information to members.
    • Publish and circulate papers, periodicals, books, and circulars beneficial to the industry.

 

  • Innovation & Research

    • Promote the discovery and investigation of inventions beneficial to the Bulk Drug Industry.
    • Support the development of new drugs and process improvements.

 

  • Market Development

    • Develop strategies to enhance indigenous and export markets for Indian Bulk Drugs.

 

  • Dispute Resolution

    • Provide arbitration and settlement services for commercial disputes between members and non-members (with mutual consent).

 

  • Quality & Research Facilities

    • Establish and maintain libraries and laboratories for testing bulk drugs and allied products.
    • Set up R&D centers for drug development and process improvements.
    • Develop Hi-tech Research & Training Centers for industry advancement.

 

  • Funding & Support

    • Accept donations and contributions from government bodies, philanthropic institutions, organizations like FAO, WHO, and individuals.

 

  • Legal & General Activities

    • Undertake all lawful activities aligned with the Association’s objectives.

© 2021 Templately copyright all right reserved